Head Of Strategy And M&A, Medical Sector (Senior Director)
Amersham, Buckinghamshire, Gb
Leading investment strategy for Americas in Medical Devices, life sciences, acute care (ICU), surgical devices and healthcare technologies Key focus areas1. Life Science tools- Bioproduction sensors, Coriolis sensors, Bioanalytical characterization instruments, Spectroscopy2. Diagnostics- Acute care, Patient monitoring, diagnostics software, imaging diagnostics3. Food SafetyRepresentative accomplishments include• • Led Halma’s entry into new medical sub- sectors like acute care, orthobiologics and software (healthcare).• Serving on boards of operating companies (Non-Executive Director, Permapure) to monitor progress and influence management at portfolio board meetings.Key transactions• Acquisition of NovaBone, leading Halma’s entry into the orthobiologics space for a consideration of upto $137 million. • Acquisition of Maxtec, leading Halma’s entry into the acute care market.• Divestiture of Fiberguide, business in the specialty optical fibers space used for photonics applications, power delivery and sensing, as well as data communications. Experience included people management, budget management and leadership experience